Alterations in genetic pathways following radiotherapy for head and neck cancer

被引:4
|
作者
Naghavi, Arash O. [1 ]
Kim, Youngchul [2 ]
Yang, George Q. [1 ]
Ahmed, Kamran A. [1 ]
Caudell, Jimmy J. [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2020年 / 42卷 / 02期
关键词
genetic pathways; head and neck cancer; radioresistance; radiotherapy; SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR; RADIATION; GROWTH; CATENIN; EXPRESSION; HYPOXIA; IDENTIFICATION; MARKER; MODEL;
D O I
10.1002/hed.26004
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Radiotherapy (RT) is an integral component in the treatment of head and neck cancer (HNC).We hypothesized there would be alterations in gene-expression and pathway activity in HNC samples obtained in recurrent HNC that were previously treated with RT, when compared to RT-naive disease. Methods Patient data was abstracted from a prospectively maintained database. Linear-microarray analysis and supervised gene-set enrichment-analysis were employed to compare RT-naive and recurrent disease after prior-RT. Results A total of 157 patients were analyzed, 96 (61%) were RT-naive and 61 (39%) had RT.After radiation, there was upregulation of genes associated with angiogenesis, protein-translation-machinery, cell-cycle regulation, and growth factors, and downregulation associated with Myc activity, and hypoxic response (all P < .001).Previously irradiated HNC was associated with downregulation in 19/42 genes in the Wnt/B-catenin-pathway (P = .045)and 119/199 genes involved in the MYC target pathway (P = .024). Conclusion Patients with recurrences salvaged surgically post-RT had significant alterations in gene-expression and in Wnt/B-catenin and MYC-target pathways. These pathways may represent potential targets to prevent development of resistance to RT.
引用
收藏
页码:312 / 320
页数:9
相关论文
共 50 条
  • [1] GENETIC ALTERATIONS IN HEAD AND NECK-CANCER
    SOMERS, KD
    SCHECHTER, GL
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 1992, 25 (05) : 1065 - 1071
  • [2] Hypoxia response pathways and radiotherapy for head and neck cancer
    Bourhis, J
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (05) : 725 - 726
  • [3] Variable genetic alterations and survival in head and neck cancer
    Gleich, LL
    Li, YQ
    Wang, X
    Stambrook, PJ
    Gluckman, JL
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (09) : 949 - 952
  • [4] Molecular techniques and genetic alterations in head and neck cancer
    Ha, Patrick K.
    Chang, Steven S.
    Glazer, Chad A.
    Califano, Joseph A.
    Sidransky, David
    ORAL ONCOLOGY, 2009, 45 (4-5) : 335 - 339
  • [5] HYPOTHYROIDISM FOLLOWING RADIOTHERAPY FOR HEAD AND NECK-CANCER
    LIENING, DA
    DUNCAN, NO
    BLAKESLEE, DB
    SMITH, DB
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1990, 103 (01) : 10 - 13
  • [6] A systematic review of smell alterations after radiotherapy for head and neck cancer
    Alvarez-Camacho, M.
    Gonella, S.
    Campbell, S.
    Scrimger, R. A.
    Wismer, W. V.
    CANCER TREATMENT REVIEWS, 2017, 54 : 110 - 121
  • [7] Auditory alterations following radiotherapy in patients with head and neck malignancy: A prospective study
    Kaul, Anirudh
    Gupta, Rohan
    Gupta, Nitika
    Kotwal, Sunil
    INDIAN JOURNAL OF OTOLOGY, 2015, 21 (02) : 119 - 123
  • [8] Variability of genetic alterations in different sites of head and neck cancer
    Rodrigo, JP
    Suárez, C
    González, MV
    Lazo, PS
    Ramos, S
    Coto, E
    Alvarez, I
    García, LA
    Martínet, JA
    LARYNGOSCOPE, 2001, 111 (07): : 1297 - 1301
  • [9] HUMAN PAPILLOMAVIRUSES AND GENETIC ALTERATIONS IN HEAD AND NECK-CANCER
    SCHOLES, A
    SNIJDERS, P
    ADAMSON, R
    WOOLGAR, J
    HART, CA
    FIELD, J
    JOURNAL OF DENTAL RESEARCH, 1995, 74 (03) : 859 - 859
  • [10] Genetic and epigenetic alterations of the WWOX gene in head and neck cancer
    Buyru, Nur
    Ekizoglu, Seda
    Koseoglu, Hikmet
    Karaman, Emin
    CANCER RESEARCH, 2014, 74 (19)